2020
DOI: 10.1080/10837450.2020.1835956
|View full text |Cite
|
Sign up to set email alerts
|

Optimized piperine–phospholipid complex with enhanced bioavailability and hepatoprotective activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 45 publications
1
7
0
Order By: Relevance
“…Advanced, high-performing and standardized Cuscuta reflexa extract phospholipid complexes were used in this study to improve the efficacy and safety of the Cuscuta reflexa plant extract. Variations in extract/phospholipid (w/ w) ratios were used to incorporate the whole extract into phytosomes, and the Box Behnken Design was used to change the desirability function for 3-factors and 3-levels 20) . Independent variables (factors) were the amount of soya lecithin and Cuscuta reflexa extract (X1) , temperature (X2) and sonication time (X3) for two dependent variables i.e.…”
mentioning
confidence: 99%
“…Advanced, high-performing and standardized Cuscuta reflexa extract phospholipid complexes were used in this study to improve the efficacy and safety of the Cuscuta reflexa plant extract. Variations in extract/phospholipid (w/ w) ratios were used to incorporate the whole extract into phytosomes, and the Box Behnken Design was used to change the desirability function for 3-factors and 3-levels 20) . Independent variables (factors) were the amount of soya lecithin and Cuscuta reflexa extract (X1) , temperature (X2) and sonication time (X3) for two dependent variables i.e.…”
mentioning
confidence: 99%
“…) of piperine and-P=O of HSPC [30]. These results were supported by PXRD, which showed piperinephospholipid complexation by reduced piperine crystallinity and amorphous state formation [30].…”
Section: Lipid-based Drug Delivery Systemsmentioning
confidence: 61%
“…These results were supported by PXRD, which showed piperinephospholipid complexation by reduced piperine crystallinity and amorphous state formation [30]. The physical mixture did not show any significant change in pharmacokinetic parameters compared to pure piperine, indicating that complexation was a determinant in pharmacokinetic improvement [30].…”
Section: Lipid-based Drug Delivery Systemsmentioning
confidence: 84%
“…The solubility of the complex in water and n- Octanol was improved by ~ 29.5-fold and ~ 3.2-fold, respectively, compared to pure PIP. Furthermore, the C max of the drug from complex (9.75 ± 2.17 μg/ml) was significantly improved compared to the C max of PIP from the pure drug (8 ± 0.21 μg/ml) [ 106 ]. These studies demonstrated phospholipid complexation’s ability to improve the drug’s bioavilability.…”
Section: Pharmacosome (Phc)mentioning
confidence: 99%